Trial intelligence / Profile preview

Lot Consistency and Non-inferiority of JE Live Attenuated SA 14-14-2 Vaccine in Infants

NCT01635816Phase 4Completed

Sponsor
icddr,b
Start
May 2012
Primary completion
Dec 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by icddr,b. Started May 2012; status: completed.

02

Drugs

japanese encephalitis vaccine sa14-14-2
03

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on NCT01635816.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01635816.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call